BORREGAARD ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17 EUR | +1.19% |
|
+1.67% | +12.29% |
| 06-19 | Borregaard Boosts Investment in Marine Biotech Alginor to NOK408 Million | MT |
| 06-14 | Borregaard to Issue NOK200 Million Commercial Paper | MT |
| Sales 2024 * | 7.92B 750M 701M 1.02B | Sales 2025 * | 8.45B 800M 748M 1.09B | Capitalization | 19.91B 1.89B 1.76B 2.56B |
|---|---|---|---|---|---|
| Net income 2024 * | 938M 88.81M 83.01M 121M | Net income 2025 * | 1.08B 103M 96.01M 140M | EV / Sales 2024 * | 2.77 x |
| Net Debt 2024 * | 2.06B 195M 182M 264M | Net Debt 2025 * | 1.84B 174M 163M 237M | EV / Sales 2025 * | 2.57 x |
| P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
18.3
x | Employees | - |
| Yield 2024 * |
2.26% | Yield 2025 * |
2.61% | Free-Float | 92.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on Borregaard ASA
More press releases
More news
| 1 day | +1.19% | ||
| 1 week | +1.67% | ||
| Current month | +1.43% | ||
| 1 month | +2.04% | ||
| 3 months | +8.14% | ||
| 6 months | +20.06% | ||
| Current year | +12.29% |
1 week
16.50
17.00
1 month
16.0417.44
Current year
13.6217.44
1 year
12.5217.44
3 years
11.7823.25
5 years
6.3123.25
10 years
6.3123.25
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 89-12-31 | |
| Director of Finance/CFO | 63 | 87-12-31 | |
Kristin Misund
CTO | Chief Tech/Sci/R&D Officer | 59 | 92-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Terje Andersen
BRD | Director/Board Member | 66 | 12-09-30 |
Margrethe Hauge
BRD | Director/Board Member | 53 | 18-03-31 |
| Director/Board Member | 58 | 12-09-30 |
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 17 | +1.19% |
| 24-06-20 | 16.8 | +0.48% |
| 24-06-19 | 16.72 | +1.09% |
| 24-06-18 | 16.54 | +0.24% |
| 24-06-17 | 16.5 | -1.32% |
Delayed Quote Deutsche Boerse AG, June 21, 2024 at 03:17 am
More quotes
Borregaard ASA is a Norway-based biorafinery. The Group provides sustainable products and solutions based on renewable raw materials. Its business model is closely linked to the integrated nature of its biorefinery in Norway, which utilises the three key components of wood cellulose fibres, lignin and sugars to produce a diversified portfolio of products. The Company operates through three business segments. BioSolutions develops, produces and sells biopolymers and biovanillin from lignin. BioMaterials develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. Fine Chemicals consists of second-generation bioethanol and intermediates mainly for contrast agents.
Sector
Specialty Chemicals
Calendar
2024-07-17
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
199.4
NOK
Average target price
208.5
NOK
Spread / Average Target
+4.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.33% | 3.77B | |
| -14.73% | 607M | |
| -28.26% | 384M | |
| -81.65% | 216M | |
| -8.97% | 117M |
- Stock Market
- Equities
- BRG Stock
- BO4 Stock
